Annual Non Current Assets
$174.68 M
-$28.81 M-14.16%
December 31, 2023
Summary
- As of February 12, 2025, FATE annual long term assets is $174.68 million, with the most recent change of -$28.81 million (-14.16%) on December 31, 2023.
- During the last 3 years, FATE annual non current assets has risen by +$46.54 million (+36.32%).
- FATE annual non current assets is now -39.36% below its all-time high of $288.04 million, reached on December 31, 2021.
Performance
FATE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$184.68 M
-$24.75 M-11.82%
September 30, 2024
Summary
- As of February 12, 2025, FATE quarterly long term assets is $184.68 million, with the most recent change of -$24.75 million (-11.82%) on September 30, 2024.
- Over the past year, FATE quarterly non current assets has increased by +$5.06 million (+2.82%).
- FATE quarterly non current assets is now -38.93% below its all-time high of $302.40 million, reached on June 30, 2021.
Performance
FATE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
FATE Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.2% | +2.8% |
3 y3 years | +36.3% | -4.0% |
5 y5 years | +2129.2% | +62.5% |
FATE Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -39.4% | at low | -35.9% | +5.7% |
5 y | 5-year | -39.4% | +132.3% | -38.9% | +145.6% |
alltime | all time | -39.4% | >+9999.0% | -38.9% | >+9999.0% |
Fate Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $184.68 M(-11.8%) |
Jun 2024 | - | $209.43 M(+19.3%) |
Mar 2024 | - | $175.52 M(+0.5%) |
Dec 2023 | $331.54 M(-34.0%) | $174.68 M(-2.7%) |
Sep 2023 | - | $179.61 M(-6.7%) |
Jun 2023 | - | $192.57 M(+0.1%) |
Mar 2023 | - | $192.45 M(-5.4%) |
Dec 2022 | $502.07 M(-20.7%) | $203.49 M(-4.9%) |
Sep 2022 | - | $214.02 M(+2.9%) |
Jun 2022 | - | $207.90 M(-19.8%) |
Mar 2022 | - | $259.31 M(-10.0%) |
Dec 2021 | $633.41 M(+28.1%) | $288.04 M(-1.0%) |
Sep 2021 | - | $290.86 M(-3.8%) |
Jun 2021 | - | $302.40 M(+25.1%) |
Mar 2021 | - | $241.65 M(+88.6%) |
Dec 2020 | $494.32 M(+117.7%) | $128.13 M(-1.2%) |
Sep 2020 | - | $129.67 M(+14.4%) |
Jun 2020 | - | $113.37 M(-0.2%) |
Mar 2020 | - | $113.64 M(+51.1%) |
Dec 2019 | $227.09 M(+10.7%) | $75.19 M(+117.5%) |
Sep 2019 | - | $34.57 M(-0.4%) |
Jun 2019 | - | $34.70 M(+0.8%) |
Mar 2019 | - | $34.44 M(+339.4%) |
Dec 2018 | $205.20 M | $7.84 M(+30.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $6.03 M(+93.0%) |
Jun 2018 | - | $3.12 M(+11.7%) |
Mar 2018 | - | $2.79 M(+3.7%) |
Dec 2017 | $102.60 M(+9.9%) | $2.70 M(+2.3%) |
Sep 2017 | - | $2.64 M(+26.1%) |
Jun 2017 | - | $2.09 M(+10.5%) |
Mar 2017 | - | $1.89 M(+9.7%) |
Dec 2016 | $93.32 M(+42.1%) | $1.73 M(-9.0%) |
Sep 2016 | - | $1.90 M(-9.1%) |
Jun 2016 | - | $2.09 M(-2.4%) |
Mar 2016 | - | $2.14 M(-7.3%) |
Dec 2015 | $65.65 M(+31.7%) | $2.31 M(+4.0%) |
Sep 2015 | - | $2.22 M(+16.0%) |
Jun 2015 | - | $1.91 M(+12.6%) |
Mar 2015 | - | $1.70 M(+28.4%) |
Dec 2014 | $49.86 M(-8.8%) | $1.32 M(-4.6%) |
Sep 2014 | - | $1.39 M(+6.1%) |
Jun 2014 | - | $1.31 M(-5.8%) |
Mar 2014 | - | $1.39 M(+48.7%) |
Dec 2013 | $54.65 M(+458.1%) | $932.00 K(-74.5%) |
Sep 2013 | - | $3.65 M(+74.9%) |
Jun 2013 | - | $2.09 M(+62.8%) |
Dec 2012 | $9.79 M(+46.4%) | $1.28 M |
Dec 2011 | $6.69 M | - |
FAQ
- What is Fate Therapeutics annual long term assets?
- What is the all time high annual non current assets for Fate Therapeutics?
- What is Fate Therapeutics annual non current assets year-on-year change?
- What is Fate Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Fate Therapeutics?
- What is Fate Therapeutics quarterly non current assets year-on-year change?
What is Fate Therapeutics annual long term assets?
The current annual non current assets of FATE is $174.68 M
What is the all time high annual non current assets for Fate Therapeutics?
Fate Therapeutics all-time high annual long term assets is $288.04 M
What is Fate Therapeutics annual non current assets year-on-year change?
Over the past year, FATE annual long term assets has changed by -$28.81 M (-14.16%)
What is Fate Therapeutics quarterly long term assets?
The current quarterly non current assets of FATE is $184.68 M
What is the all time high quarterly non current assets for Fate Therapeutics?
Fate Therapeutics all-time high quarterly long term assets is $302.40 M
What is Fate Therapeutics quarterly non current assets year-on-year change?
Over the past year, FATE quarterly long term assets has changed by +$5.06 M (+2.82%)